Zynex, Inc. Appoints Brian Alleman as Chief Financial Officer
July 21, 2014 at 05:30 pm IST
Share
Zynex, Inc. announced the appointment of Brian Alleman as its new chief financial officer. Mr. Alleman has over 25 years of experience serving both public and private companies in the role of CEO, COO and CFO. He most recently served as managing director at Alleman & Associates.
Mr. Alleman has served on five public company boards throughout his career and has years of experience assisting companies with corporate turnarounds, capital raising, strategic planning, business development, finance, investor relations and other strategic business issues.
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Companyâs devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Companyâs products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.